Medical Science Liaison/Senior Medical Science Liaison, Migraine (South Region)

The role

The MSL/Senior MSL will execute the national medical affairs plan within a specified territory. This person will communicate Axsome science and develop relationships with healthcare professionals to support the migraine franchise.

What you will do

• Identify and develop relationships with healthcare professionals
• Provide fair and balanced scientific information to HCPs and internal partners
• Provide formal presentations to HCPs and external stakeholders upon request
• Lead scientific discovery and communicate insights from peer-to-peer discussions
• Identify, analyze, and translate territory needs to achieve objectives
• Collaborate with internal partners to advance clinical and business objectives
• Build and maintain technical and clinical expertise in migraine and neuroscience
• Maintain knowledge of global and regional market issues and product knowledge
• Contribute to the growth and development of the National Migraine Medical Team
• Execute documentation, medical information requests, expense reports, and required trainings

Required qualifications

• Advanced degree (MD, PharmD, DO, APNP or PhD)
• Must reside within the geographic area
• Ability to travel up to 75%, including overnight stays and weekends
• Meet requirements for health industry personnel credentialing to gain access to healthcare facilities
• Ability to thrive in an entrepreneurial and autonomous environment
• Strong attention to detail and excellent organization skills
• Strong interpersonal skills and communication skills
• Ability to translate data and converse appropriately with the intended audience
• Ability to multi-task in a fast-paced environment
• Problem solving oriented

Nice to have

• Previous MSL experience
• Neurology, neuroscience, migraine and/or fibromyalgia experience

Benefits

• Annual bonus
• Significant equity
• Generous benefits package

About the company

Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. Their neuroscience portfolio includes FDA-approved treatments for major depressive disorder, agitation associated with dementia due to Alzheimer’s disease, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine.